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The purpose of this Capstone Project was to design a strategy for implementing 
an oncology clinical research program at a rural hospital cancer center. The rural cancer 
center is part of a large healthcare system (Healthcare System) that encompasses several 
hospitals located throughout northern Illinois. Healthcare System administrators 
prioritized development of a research program at the rural hospital as part of an 
institution initiative to expand access to oncology clinical trials in the community and 
rural settings. The author of this project was tasked with the responsibility of developing 
a strategy for building this research program at the rural cancer center. The project was 
accomplished by conducting a literature review, completing a needs assessment, and 
reviewing hospital analytic data. The literature review was used to identify best practices 
for opening and managing clinical research programs and to identify concerns specific to 
rural hospitals. The needs assessment was completed with key individuals in the 
oncology and research departments in the Healthcare System to gather information to 
ensure that the proposed strategy met the requirements of the oncology physicians and 
oncology and research leadership. The information from the literature review was then 
combined with feedback from the needs assessment and hospital analytic data to create a 
strategy that will provide a foundation for an oncology research program at the rural 
hospital that meets the needs of the patients, physicians, and Healthcare System 
administrators. 
                Based on the literature review, needs assessment responses, and the rural 
hospital analytic data, a strategy was proposed that includes the following 




which trials to include in the clinical trial portfolio, (2) include studies in the portfolio 
that are likely to accrue, are less complex, and focus on chemotherapy treatments, (3) 
initially open breast, lung, and prostate studies, (4) staff the research program at the rural 
cancer center with a clinical research nurse on a consistent part-time basis, (5) educate 
the clinical staff on research activities to promote collaboration, and (6) track study 
metrics to monitor research personnel workload. The goal of this strategy is to build an 
initial research program that will succeed in the current environment at the rural cancer 
center, which is naive to research. Ultimately, the strategy should be modified as the 
research program grows and investigators gain experience to bring on additional and 
more complex trials. Extra research staff should be hired as needed. While the strategy 
proposed in this project is designed specifically for a small rural cancer center, the 
recommendations may still apply to other larger programs since having effective 
processes for choosing appropriate trials and providing adequate staffing support are 
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Commission on Cancer. “…a consortium of professional organizations dedicated to 
improving survival and quality of life for cancer patients through standard-setting, 
which promotes cancer prevention, research, education, and monitoring of 
comprehensive quality care.”1 The consortium accredits facilities complying with 
the established standards.2  
 
Community Cancer Program. A category of cancer program achieved through the 
Commission on Cancer accreditation program. “The facility accessions more than 
100 but fewer than 500 newly diagnosed cancer cases each year and provides a 
full range of diagnostic and treatment services, but referral for a portion of 
diagnosis or treatment may occur.”3 
 
Comprehensive Cancer Center. “A cancer research center that gets support from the 
National Cancer Institute (NCI) to do cancer research and provide services 
directly to cancer patients. Scientists and doctors at these centers do basic 
laboratory research and clinical trials, and they study the patterns, causes, and 
control of cancer in groups of people. Also, they take part in multicenter clinical 
trials, which enroll patients from many parts of the country.”4 
 
Cooperative Group Trials. “A group of researchers, cancer centers, and community 
doctors who are involved in studies that test new ways to screen, prevent, 
diagnose, and treat cancer. Clinical trials run by cooperative groups are funded 
and supported by the National Cancer Institute (NCI), and large numbers of 
patients take part in many locations.”5 The cooperative groups included in this 
definition are the Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer 
Research Group, and SWOG. 
 
Observational Study. “A type of study in which individuals are observed or certain 
outcomes are measured. No attempt is made to affect the outcome (for example, 
no treatment is given).”6 
 
Phase I Trial. “The first step in testing a new treatment in humans. A phase I study tests 
the safety, side effects, best dose, and timing of a new treatment. It may also test 
the best way to give a new treatment (for example, by mouth, infusion into a vein, 
                                                        
1 American College of Surgeons, Cancer Program Standards: Ensuring Patient-Centered Care, Chicago: 
American College of Surgeons, 2015, 4, https://www.facs.org/~/media/files/ quality%20programs/cancer/ 
coc/2016%20coc%20standards%20manual_interactive%20pdf.ashx. 
2 American College of Surgeons, 4. 
3 American College of Surgeons, 8. 
4 “NCI Dictionary of Cancer Terms,” National Cancer Institute, accessed March 6, 2019, 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/comprehensive-cancer-center. 
5 “NCI Dictionary of Cancer Terms,” National Cancer Institute, accessed March 6, 2019, 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nci-clinical-trials-cooperative-group. 





or injection) and how the treatment affects the body. The dose is usually increased 
a little at a time in order to find the highest dose that does not cause harmful side 
effects. Phase I clinical trials usually include only a small number of patients who 
have not been helped by other treatments. Sometimes they include healthy 
volunteers.”7 
 
Phase II Trial. “A study that tests whether a new treatment works for a certain type of 
cancer or other disease (for example, whether it shrinks a tumor or improves 
blood test results). Phase II clinical trials may also provide more information 
about the safety of the new treatment and how the treatment affects the body.”8 
 
Phase III Trial. “A study that tests the safety and how well a new treatment works 
compared with a standard treatment. For example, phase III clinical trials may 





                                                        
7 “NCI Dictionary of Cancer Terms,” National Cancer Institute, accessed March 6, 2019, 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-i-clinical-trial. 
8 “NCI Dictionary of Cancer Terms,” National Cancer Institute, accessed March 6, 2019, 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-ii-clinical-trial. 









 In December 2015, a small rural hospital in northern Illinois merged with a large 
healthcare system (Healthcare System) in the region. The small hospital is a ninety-eight 
bed facility and includes a cancer center. The cancer center provides the community with 
access to medical oncologists and treatment options including surgery, chemotherapy, 
and radiation. The main hospital in the Healthcare System is located in a large 
metropolitan area and is a leading academic medical center housing a National Cancer 
Institute designated Comprehensive Cancer Center (CCC). The CCC offers hundreds of 
clinical trials to oncology patients.  
While the rural cancer center provides several treatment options for patients close 
to home, it is not able to offer local access to clinical trials because the infrastructure does 
not exist at the rural hospital to support research. The cancer center physicians, instead, 
have to refer patients to the CCC or other hospitals in the system for clinical trial 
participation. While having access to research studies through the CCC is a benefit to the 
patients, the downside is that the patients have to travel over an hour away for their care. 
A negative for the oncologists at the rural cancer center is that they could potentially lose 
the relationship that they have with their patients should their patients decide to remain 
under the care of a physician at the CCC.  
 In fiscal year 2019, the Healthcare System made the expansion of oncology 
clinical research into four of the System’s community hospitals, including the rural 




a large metropolitan area, and the rural hospital is located farther west situated in Illinois’ 
farmland. These community hospitals allow the Healthcare System to provide care to 
patients in more convenient locations close to their homes. The Oncology Research 
Integration Committee (Committee) was established by Healthcare System leadership to 
oversee and direct the expansion of oncology research into the community hospitals. The 
Committee consists of members from across the Healthcare System representing the 
CCC, the Office of Research, research compliance, and the oncology service line. The 
Committee proposed that bringing access to clinical trials to patients in their own 
communities would benefit patients as they may be more inclined to participate in studies 
if the treatments are at easily accessible locations. The Committee also advised that 
expansion would benefit the physicians since they would be able to offer clinical trials to 
patients at their own practice rather than refer them to another location. Additionally, the 
Healthcare System could increase its reputation in the region by being able to promote 
access to clinical trials and cutting-edge medical care in the community setting.  
1.2. Statement of the Problem 
 
Three of the community hospitals designated for research expansion already have 
an infrastructure in place to support research. The rural hospital, however, has no 
research program on site. The author of this Capstone Project is an operations manager in 
the clinical research program at the Healthcare System and became the person 
responsible for developing a plan to support clinical trials at the rural hospital.  





1. It was a directive of the Healthcare System executives as a strategy to improve 
patient satisfaction and care.  
2. The rural hospital is seeking accreditation as a Community Cancer Program 
(CCP) through the Commission on CancerⓇ. To be a compliant CCP, the cancer 
center must accrue at least two percent of its patients, based on annual analytic 
cases, to clinical trials.10 Patients referred to other institutions where they are 
enrolled on trials do count toward the required accrual amount.11 However, as 
noted previously, a benefit of the expansion is to prevent physicians from having 
to refer patients and potentially lose their patients to another oncologist or medical 
practice. Without a research program in place, the rural cancer center would not 
have the appropriate resources to promote clinical trials and enroll patients on 
studies. This lack of research support could lead to the hospital not being 
compliant with the clinical trial accrual standard and not receiving the CCP 
accreditation.  
3. The expansion serves to benefit patients, physicians, and oncology leadership at 
the rural hospital. Most cancer patients tend to be diagnosed and treated in the 
community rather than at an academic medical facility12 so the patients would 
have an advantage with clinical trial options close to home. It has long been a 
desire of the physicians and oncology leadership to have a research presence at 
the rural cancer center to better support the rural community.  
                                                        
10 American College of Surgeons, 41. 
11 American College of Surgeons, 42. 
12 Ronald S. Go et al., "Clinical Trial Accrual among New Cancer Patients at a Community-Based Cancer 




1.3. Addressing the Problem 
 
In order to support the expansion of clinical research at the rural hospital, a 
research office needs to exist at the facility to provide guidance and oversight of the 
research. Some of the research program operational areas that need to be implemented at 
the rural hospital include, but are not limited to, contract reviews, budget negotiations, 
research billing, study feasibility assessment, and study coordinator and regulatory 
support. The rural hospital can utilize existing system-wide research processes and 
services to address many of these issues. For example, the rural hospital research 
program can use the Healthcare System’s Office of Research for contract review and 
budget negotiations. The process for research billing review is managed by the Office of 
Research and is built into the Healthcare System’s electronic medical record shared by all 
of the hospitals. While these particular activities are already supported, there are other 
operations, such as study feasibility and staffing support, that need to be addressed 
specifically for a small hospital. The rural hospital has to consider staffing support 
limitations, whether the services and equipment are available to execute protocol required 
treatments, and whether an adequate population exists to enroll patients on a protocol. 
These site-specific needs were taken into consideration during the process of developing 
the strategy to implement a research program at the rural hospital.13  
1.4. Project Questions 
 
The goal of this Capstone Project was to provide a strategy for implementing a 
research program at the rural hospital that would be successful in accruing patients and 
that would also meet the needs of the oncology physicians and oncology and research 
                                                        




department administrators. There are reports in the literature that research programs can 
be a drain on institution resources especially if studies are opened that result in limited or 
no accrual14. Therefore, the author of this project investigated key elements to consider 
when developing a research program to ensure a productive program rather than a 
stagnant or failing one. A literature review of clinical research program management led 
the author to determine that development of a practical clinical trial portfolio and 
appropriate staffing of the research program were crucial elements to incorporate into the 
strategy for building a research program at the rural hospital. This decision was primarily 
based on the article by Allison Baer et al. that suggested appropriate management of 
these items is critical to having an efficient research program.15 Therefore, this Capstone 
Project focused on identifying methods for how best to build a clinical trial portfolio and 
how to appropriately staff the research program at the rural hospital. Additionally, the 
needs of physician investigators, oncology administration, and research leadership were 
assessed to ensure that the research program strategy aligned with the visions of these 
stakeholders. A research program may be more likely to thrive with physician and 
administration support and engagement.16 
                                                        
14 Henry Durivage and Kerry Bridges, 2009, “Clinical Trial Metrics: Protocol Performance and Resource 
Utilization from 14 Cancer Centers,” Poster presented at the 2009 American Society of Clinical Oncology 
annual meeting, Orlando, FL, May 29-June 2, 2009, https://forteresearch.com/wp-content/uploads/2017/10/ 
asco-poster_2009.pdf. 
15 Allison R. Baer et al., "Clinical Research Site Infrastructure and Efficiency," Journal of Oncology 
Practice 6, no. 5 (September 2010): 251, https://doi.org/10.1200/JOP.000109.  
16 Baer et al., "Clinical Research Site Infrastructure and Efficiency," 251; Eileen P. Dimond et al., "Creating 
a “culture of research” in a community hospital: Strategies and tools from the National Cancer Institute 









The first objective of this Capstone Project was to gather information regarding 
implementing and managing a clinical research program at a small rural hospital. Part of 
this information came from a literature search focusing on oncology healthcare in rural 
locations, research program development, clinical trial feasibility and selection, and 
methods for determining adequate research staffing support. The other data came from a 
needs assessment questionnaire that was developed and administered by the author to key 
stakeholders in the form of an oral interview. The stakeholders represented the oncology 
physician investigators at the rural hospital, administration at the rural hospital, and 
leadership in the Healthcare System’s Office of Research. To supplement the literature 
review and needs assessment, data was requested from the rural hospital’s cancer registry 
in order to have a better understanding of the cancer population served at the hospital.  
The second objective of this Capstone Project was to use the data gained from the 
literature review, needs assessment interviews, and cancer registry analytic data to 
develop a strategy for implementing clinical research at the rural hospital. The strategy 
included recommendations for developing a clinical trial portfolio that is specific to the 
patient population but that also engages the physicians so that the chance of patient 
accrual is maximized. In addition, the strategy provided guidance on how best to support 
the research program from a staffing perspective. The plan for staffing had to consider 
the anticipated workload for managing the initial studies and accrual but also supporting 




final strategic plan will be provided to healthcare administration in both the oncology and 
research programs.  
1.6. Significance 
 
 The American Cancer Society predicts that in 2019 over 1.7 million people will 
be diagnosed with a new cancer.17 Clinical trials are essential in getting new treatments to 
market to help these individuals, but clinical trials only succeed if patients are enrolled on 
the studies.18 As stated previously, since most cancer patients receive care in their 
community,19 it is important to bring clinical trial opportunities to patients at convenient 
locations close to their homes. Local access to clinical trials may increase the chances of 
patients agreeing to participate in research. A rural location has specific needs to consider 
when developing a research program, and the information presented in this Capstone 
Project may help other rural or small facilities be able to implement and manage an 
effective clinical research program. The scope of this project, however, should not be 
limited to only rural facilities as the expectation is that the strategy presented in this paper 
can be applied to other larger institutions developing research programs. 
 The significance specifically for the Healthcare System is that initiating clinical 
trials at the rural cancer center accomplishes a strategic goal to expand oncology clinical 
research to the communities. Patient satisfaction within the Healthcare System will 
hopefully increase since patients do not have to commute far from home to obtain 
treatment in clinical trials. Physician satisfaction should also increase knowing that they 
can provide clinical trial access to their patients without having to refer them to another 
                                                        
17 American Cancer Society, Cancer Facts & Figures 2019, Atlanta: American Cancer Society, 2019, 1, 
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-
and-figures/2019/cancer-facts-and-figures-2019.pdf. 
18 American Cancer Society, 67. 




oncologist. Ultimately, the Healthcare System’s reputation as a mecca for oncology 
treatments may grow in the region as the knowledge spreads that cutting-edge trials can 
be received at several hospital locations. 
1.7. Exclusions and Limitations 
 
A limitation to this Capstone Project is that not all areas of research program 
development are discussed. Since the Healthcare System already has an established 
research program through the Office of Research, not all operational processes had to be 
developed. For example, the Office of Research supports a Clinical Trial Management 
System that the rural hospital can use to track patient visits and program finances. The 
scope of existing policies and procedures for human subjects research can be modified to 
include the rural hospital rather than having to develop policies and procedures from 
scratch specifically for the rural cancer center. Clinical Trial Agreement review and 
budget negotiation processes already exist with the Office of Research, and the research 
program in the rural hospital will utilize these established methods. Instead, this Capstone 
Project focuses on two main items that are site specific: creating a clinical trial portfolio 
that will be successful in accruing patients at the rural hospital and determining a staffing 




Chapter 2. Literature Review 
 
 
2.1. Overview of the Literature Review 
 
 A preliminary literature search related to clinical research program development 
was conducted and led to an article by Robin Zon et al. This article is the compilation of 
feedback from individuals working in the clinical research field, and Zon et al. analyze 
this information and provide a list of “Exemplary Attributes”20 which other research sites 
can utilize to evaluate their own programs. The article suggests that a site should 
concentrate on creating a diversified clinical trial portfolio that can offer several options 
to patients. In addition, the portfolio should include studies that address the specific needs 
of the patients at the site, such as cancer type and stage.21 This recommendation of 
building a diversified and practical trial portfolio is echoed in the article by Baer et al.22 
Baer et al. consider a well-balanced clinical trial portfolio to be key to a successful 
research site, and they also note the importance of the effective use of resources, such as 
staff, in creating an efficient research program.23 Based on these two articles, a more in-
depth review of the literature was completed to identify sources that discussed best 
practices for developing a clinical trial portfolio and methods for effectively providing 
staffing support. Literature was also consulted to identify issues specific to a small 
community hospital that should be considered for this project.  
                                                        
20 Robin Zon et al., "American Society of Clinical Oncology Statement on Minimum Standards and 
Exemplary Attributes of Clinical Trial Sites," Journal of Clinical Oncology 26, no. 15 (May 20, 2008): 
2562-2567, https://doi.org/10.1200/JCO.2007.15.6398.  
21 Zon et al., "American Society of Clinical Oncology Statement on Minimum Standards and Exemplary 
Attributes of Clinical Trial Sites," 2565. 
22 Baer et al., "Clinical Research Site Infrastructure and Efficiency," 249-252. 




2.2. Considerations for Clinical Trial Portfolio Development 
 
 Ronald Go et al. completed a prospective study at their community-based medical 
oncology center. The authors assessed the limitations at their facility that prevented them 
from being able to accrue more patients on clinical trials. The study concluded that out of 
all of the patients that did not participate in trials, sixty-six percent did not enroll because 
a study was not open at the site for which they were eligible. The site either did not have 
a trial open that targeted their specific cancer type or the site did not have a trial that was 
directed toward their specific stage of cancer. The authors proposed that the clinical 
research portfolio does not need to be increased dramatically at sites to include all cancer 
types and stages but rather the clinical research portfolio should be carefully reviewed 
and studies opened that cater to the needs of the patient population seen at the facility.24  
 Other articles agree with this need to open trials that are applicable to the patients 
and their disease state and offer further discussion on how best to establish this 
diversified portfolio. Baer et al. suggest that studies should be offered at a site that cover 
various treatment options for patients. For example, a patient can be treated with 
radiation therapy followed by chemotherapy. The site may want to have a clinical trial for 
the radiation therapy as well as study options for the chemotherapy.25 Mark Porter et al. 
propose that sites should have studies available for the same cancer type but with 
different inclusion and exclusion criteria so that patients not eligible for one study may 
                                                        
24 Go et al., 431. 
25 Allison R. Baer et al., "Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical 





still have options for participating in another trial.26 An additional suggestion regarding 
clinical trial selection is to include Phase I, II, and III trials and registry and tissue 
banking studies for a fully diversified portfolio.27  Sites may also want to incorporate 
studies for healthy volunteers so that family and friends can participate in research as 
well.28 
Research sites with budgetary concerns may need to have a clinical trial portfolio 
that incorporates studies with various sponsors and funding levels such as cooperative 
group studies, investigator initiated studies, and industry-sponsored studies. Studies 
funded by industry, in general, tend to cover the site’s costs associated with participation 
in the trial. The revenue received from industry studies can then help to offset money lost 
in participating in investigator initiated and cooperative group studies, which have limited 
budgets that usually do not cover the site’s costs.29 
Zon et al., in their list of “Exemplary Attributes,” advise that model sites should 
strive to enroll at least ten percent of their patients into clinical trials.30 Part of being able 
to achieve such a lofty goal is selecting studies applicable to the patient population. This 
is a high bar to reach so sites may need to consider other criteria before choosing to open 
a study. One such criterion is that sites should review the current trial accrual statistics if 
the study is open at other sites. If a trial is not meeting the enrollment expectations 
                                                        
26 Mark Porter et al., "A Comprehensive Program for the Enhancement of Accrual to Clinical 
Trials," Annals of Surgical Oncology 23, no. 7 (July 1, 2016): 2148, https://doi.org/10.1245/s10434-016-
5091-9. 
27 Zon et al., "American Society of Clinical Oncology Statement on Minimum Standards and Exemplary 
Attributes of Clinical Trial Sites," 2565. 
28 Zon et al., "American Society of Clinical Oncology Statement on Minimum Standards and Exemplary 
Attributes of Clinical Trial Sites," 2565; Baer et al., "Implementing Clinical Trials: A Review of the 
Attributes of Exemplary Clinical Trial Sites," 328. 
29 Baer et al., "Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial 
Sites," 328. 
30 Zon et al., "American Society of Clinical Oncology Statement on Minimum Standards and Exemplary 




nationally, the site may want to thoroughly review the eligibility criteria to determine 
whether they could be successful in accruing patients.31 The site should also monitor the 
enrollment timeline for the study. If enrollment is almost complete, it may not be worth 
the site’s resources to open a study and then have no time to accrue patients.32 Research 
centers can also choose to hold the site principal investigators accountable during the 
study selection process. As an example, Henry Durivage and Kerry Bridges report that 
their institutions, the Cancer Institute of New Jersey and the Indiana University Simon 
Cancer Center, respectively, require principal investigators to provide proof that they will 
be able to accrue patients to their studies as part of the protocol submission process. 
Implementation of this requirement led to a significant reduction in the number of trials 
with no accruals at the two cancer centers.33 Finally, research sites should get feedback 
from the physicians because study accrual is dependent on physician engagement. 
Physicians that are able to participate in study selection and believe in the studies and the 
treatments that they offer may be more likely to refer patients to the trials.34 
Developing a clinical trial portfolio that accrues patients is important to a site’s 
budget and resources. The study by Durivage and Bridges analyzed data from fourteen 
cancer centers. Just over half of the studies opened at the cancer centers did not accrue 
any patients, and almost twenty percent of the studies only accrued one to two patients. 
Studies with no patients enrolled still require resources and effort to cover regulatory 
submissions, trainings, investigator meeting attendance, screening patients, and planning 
                                                        
31 Baer et al., "Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial 
Sites," 329. 
32 Baer et al., "Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial 
Sites," 329. 
33 Durivage and Bridges. 
34 Baer et al., "Clinical Research Site Infrastructure and Efficiency," 251; Robin Zon et al., "Part 2: 
Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial Sites," Journal of 




during the study start-up phase.35 Durivage and Bridges calculate that a cancer center, 
with similar low accrual metrics, can lose up to $81,000 per year.36 
 In order to incorporate all of these suggestions regarding development of a 
productive and diverse clinical trial portfolio, it is recommended that committees be 
utilized to review the feasibility of the study at the site and to determine whether or not to 
open the trial.37 Baer et al. recommend that the protocol be evaluated to ensure that the 
site has the appropriate equipment and resources to conduct the study, that the population 
exists in order to accrue to the study, and that the study fits into the existing clinical trial 
portfolio by offering a needed treatment without competing with another study.38 As an 
example, The Ohio State University Comprehensive Cancer Center, in an effort to 
increase accrual to clinical trials, identified four areas for improvement. One area of 
improvement was to give the responsibility of study selection to the Disease-Specific 
Committees. This operational change allowed the disease experts to review trials and 
choose those appropriate for the patient population. The cancer center also included a 
goal of opening studies for each cancer type and stage treated at the facility. Prior to 
making any of the operational changes at the cancer center, Porter et al. report accruing 
less than fifteen percent of patients onto trials. After implementing the changes to 
improve accrual, Porter et al. present in their paper an increase in accrual with twenty-
five percent of patients enrolling in studies.39  
                                                        
35 Durivage and Bridges. 
36 Durivage and Bridges. 
37 Porter et al., 2147-2148; Baer et al., "Clinical Research Site Infrastructure and Efficiency," 251. 
38 Baer et al., "Clinical Research Site Infrastructure and Efficiency," 251. 





2.3. Considerations for Staffing the Program 
 
 A study by Carol Somkin et al. reviewed potential barriers to oncology clinical 
trial participation. One noted impediment to patient accrual was lack of adequate 
dedicated research staff to manage trial enrollment.40 Research staff are an important part 
of the research infrastructure, and there continues to be a dilemma in the clinical research 
community on how best to support clinical research programs with personnel. Clare 
Hastings et al. suggest that the best individuals to manage clinical trials are clinical 
research nurses.41 Clinical research nurses have the clinical background to appropriately 
assess patients for adverse events and, depending on training, may have the ability to 
administer investigational drugs and participate in study procedures. At the same time, 
the nurses are also trained in research activities such as the informed consent process and 
the study protocol. The authors, therefore, consider the clinical research nurse to be a key 
player in supporting a clinical research program. The article specifically notes that a 
clinical research nurse would be a sensible option for a smaller facility since the nurse 
could complete both clinical assessments and research protocol requirements.42 
While the Hastings et al. article documents the need for a clinical research 
nurse43, the article by Somkin et al. notes that involvement of clinical nursing staff in the 
research studies is beneficial to study accrual.44 A collaborative effort between research 
                                                        
40 Carol P. Somkin et al., “Organizational Barriers to Physician Participation in Cancer Clinical Trials,” 
American Journal of Managed Care 11 (July 2005), https://www.ajmc.com/journals/issue/2005/2005-07-
vol11-n7/jul05-2081p413-421. 
41 Clare E. Hastings, Cheryl A. Fisher, and Margaret A. McCabe, “Clinical research nursing: A critical 
resource in the national research enterprise,” Nursing Outlook 60 (2012): 151-152, 
https://doi.org/10.1016/j.outlook.2011.10.003. 
42 Hastings, Fisher, and McCabe, 151-152. 
43 Hastings, Fisher, and McCabe, 151-152. 




staff and clinic staff may be key in operationalizing an efficient research program. This 
research and clinical staff partnership is documented in an article by Diane St. Germain 
that reports on cancer centers embracing the use of clinical nurse navigators in helping to 
identify potential clinical trial participants. One center in the study, which is part of 
Spartanburg Regional HealthCare, implemented a system where a research nurse was 
paired with a nurse navigator. The involvement of the nurse navigator allowed the 
screening and enrollment process to go more smoothly because the clinical nurse already 
had a relationship with the patient, understood the patient’s disease state, and was in a 
position to coordinate the patient’s care with any clinical trial protocol requirements.45 
Louis Barr, Jane Crofton, and Yu-Hsin Annie Lin also report a positive result of 
increased trial accrual at their institution, the Florida Hospital Cancer Institute, since 
asking nurse navigators to be more involved in the clinical research process. The nurse 
navigator is able to direct patients to the appropriate study team and provide information 
to the patients regarding the trials.46 
A research program, even though it may be able to depend on support from 
clinical staff, needs to supply appropriate research staff to manage the clinical trials and 
the accrual. There is some disagreement in the literature on how best to calculate research 
coordinator or research nurse workload to determine the number of staff required to 
support the clinical trial portfolio. As cited by Pam James et al., the National Cancer 
Institute suggests that one full-time employee can manage about thirty research patients 
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in an active status and fifty patients in follow-up. A limitation to this recommendation is 
that it does not account for trial type and complexity.47 Therefore, James et al. initiated 
their own metric tracking system at their institution to more accurately capture research 
staff time and effort, which allowed them to make better decisions regarding resource 
allocation.48 Noting also the limitations of the National Cancer Institute workload 
suggestion, Marjorie Good et al. created a scoring system to try and incorporate the 
complexity of a clinical trial into workload determinations. In this system, clinical trial 
protocols involving multiple drugs and randomizations receive a higher score than an 
observational study. These scores are then used as multipliers when calculating the 
workload of a research nurse. Good et al. came to the conclusion that a score of thirty-
five to forty using their system was a maximum workload for research staff.49 An article 
by Bobbi Smuck et al. also proposes a protocol scoring system to try and incorporate trial 
complexity into workload analysis. In this system, a Phase I trial receives a score of eight 
and a non-treatment trial with only one visit receives a score of one. The intent is for 
managers to use this scoring system to better anticipate staffing needs.50  
2.4. Considerations Specific to Opening a Research Program at a Small Rural 
Hospital 
 
  An article discussing clinical trial implementation at community cancer centers 
suggests that the centers focus on two areas: opening trials that are most likely to accrue 
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patients and initially opening trials offering chemotherapy as a treatment. The goal of 
offering these types of trials is to engage the physicians in research. Physicians may be 
more likely to participate in clinical trials if it easy to identify patients to enroll and if 
familiar treatment options, such as chemotherapy, are offered in the trial.51 The study by 
Go et al. provides additional insight for opening studies in the community setting with 
smaller research programs. The authors note that feasibility assessments must consider 
the institution budget and available resources since those may not be as prevalent at a 
smaller facility. Also, the protocol should be thoroughly reviewed to ensure that the site 
has the appropriate equipment and expertise to complete all of the protocol required 
treatments and procedures.52 Baer et al. provide guidance on opening a new research 
program and recommend that the first trials opened should correspond to the site’s largest 
patient population to ensure high accrual rates. New sites should also initially open less 
complex trials, such as quality of life studies, so that the research team can gain 
experience in research procedures and requirements. Once the program is running 
smoothly, then sites can begin to grow and diversify their clinical trial portfolio.53
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Chapter 3. Needs Assessment 
 
 
3.1. Establishing the Need for a Clinical Research Program at the Rural Hospital 
 
There are three primary reasons for establishing a clinical research program at the 
rural hospital. First, an aim of the Oncology Research Integration Committee 
(Committee) is to ensure that all hospitals in the Healthcare System can participate in 
clinical trials by enrolling patients into studies and administering protocol required 
treatments and procedures at the facilities. The lack of research support at the rural 
hospital was recognized as a barrier to carrying out the research expansion. Therefore, the 
author of this paper, with input from the Committee, determined that implementing a 
research program at the rural hospital was a priority. 
The second reason is that the rural hospital is attempting to earn the CCP 
accreditation from the Commission on CancerⓇ. As the operations manager for the 
oncology research program, the author of this project attends the hospital’s Commission 
on CancerⓇ Committee meeting and is responsible for reporting clinical trial accrual 
numbers. Accruing two percent of patients to clinical trials per year is required to achieve 
compliance with Commission on CancerⓇ Standard 1.9: Clinical Research Accrual.54 
Less than two percent accrual has been reported at these meetings for the rural hospital, 
and accruals that are reported are referrals to other institutions. This need to increase 
clinical trial enrollment to comply with the standard is another factor in deciding to 
implement a research program at the hospital. Having infrastructure in place at the rural 
                                                        




cancer center will allow patients to be enrolled in studies locally and give the site the 
support necessary to exceed the minimum two percent accrual requirement. 
The final reason is that since the rural hospital became a part of the larger 
Healthcare System in December 2015, integration efforts have been ongoing to include 
the rural hospital oncology program in existing healthcare system oncology operations, 
which includes clinical research. For example, videoconferencing has allowed physicians 
at all hospital locations to join together to discuss patient cases at Tumor Board meetings. 
At Tumor Board, two areas are discussed: treatment plans for patients to determine the 
best course of action and patient eligibility for clinical trials. This increase in 
collaboration across the Healthcare System is what prompted the rural oncologists to 
expect the same level of research support and opportunity that exist at other hospitals. 
The rural hospital oncologists began asking administration when clinical research could 
be supported at the rural hospital.  
Both the Oncology Research Integration Committee and the rural hospital’s 
Commission on Cancer CommitteeⓇ played a role in identifying the need for developing 
a clinical research program at the rural cancer center. As an operations manager 
supporting the oncology research program, this author was tasked with the responsibility 
of developing a strategy to build a successful research program at the rural community 





Chapter 4. Project Description 
 
 
4.1. Description of Project Components 
 
 The goal of this Capstone Project was to develop a strategy for implementing a 
clinical research program at the rural hospital. To accomplish this task, the project was 
divided into two components. The first part of the project was to gather data regarding 
clinical research program development and needs specific to rural healthcare programs. 
This data collection was achieved through a literature review, administration of a needs 
assessment, and requesting data from the cancer registry at the rural hospital. The 
literature review was completed using key search criteria related to rural healthcare, 
clinical trial portfolio development, research staffing, and research program management. 
The literature review was planned so that the author could gain knowledge of best 
practices and lessons learned from other research institutions. The needs assessment was 
included as part of the data collection in order to gather information specific to the rural 
hospital. The needs assessment was designed for oncology physicians at the rural 
hospital, the oncology department director at the rural hospital, and the Healthcare 
System research manager. Questions were written to obtain these individuals’ feedback 
on staffing concerns and requests, their requirements for clinical trials to be offered at the 
rural hospital, and their overall vision and desires for the research program. The needs 
assessment was administered in an interview format. The cancer registry data provided 
information regarding the patient population seen at the rural cancer center.  
 The second component of this project was to analyze the data from the literature 
review, the needs assessment, and the cancer registry to create a strategy to build a 




was used as a foundation for the strategy. The needs assessment responses and the cancer 
registry information were then used by the author to cater the strategy specific to the 
needs of the rural hospital. For the end result of the project, a strategy was produced 
providing the rural hospital with recommendations for staffing the program and building 








Chapter 5. Methodology 
 
 
5.1. Project Design 
 
 The methodology for this project included a two-step approach. The first step was 
to collect data regarding implementing a clinical research program at a rural hospital 
through a literature review, a needs assessment, and a data request from the rural 
hospital’s cancer registry. The second step was to analyze the information collected and 
produce a strategy to guide the establishment of a research program at the rural hospital.  
5.2. Discussion of Literature Review Methods 
 
 A literature review was conducted through the PubMed search engine. Searches 
included the following topics: 
1. Oncology healthcare in the rural setting 
2. Clinical research program development and management 
3. Clinical Trial Portfolio Development 
4. Clinical Research Staffing Assessments. 
The initial PubMed search for clinical program development and management led to the 
article by Baer et al. which noted that a carefully considered clinical trial portfolio and 
appropriate staffing are key to having a successful research program.55 Based on the Baer 
et al. article, the literature search was expanded on PubMed to include articles 
encompassing clinical trial portfolio development and assessing research staffing needs. 
A review of the literature was also conducted by accessing the resources and articles 
supplied on the National Cancer Institute AccuralNetTM website. AccrualNetTM provides 
                                                        




support to oncology research sites in the form of education and tools for managing and 
increasing study accruals.56 Similar to the PubMed search, articles related to rural 
healthcare, research program development and management, clinical trial portfolios, and 
research staffing were reviewed. The articles obtained through the literature searches 
were reviewed for best practice recommendations and methods for establishing a clinical 
research program with an emphasis on clinical trial portfolio development and 
appropriate staffing. 
5.3. Discussion of Needs Assessment 
 
 While there was much knowledge gained from reviewing the literature, it was 
also important to obtain feedback from key stakeholders in the Healthcare System’s 
oncology and research departments. The feedback from these individuals was used to 
ensure that the strategy developed for implementing a research program at the rural 
hospital met the needs of the physician investigators and applicable administrators.  
 
5.3.1. Selection of needs assessment respondents 
 
Six representatives were selected by the author to participate in the needs 
assessment. These individuals’ roles are listed along with their initials, which is how they 
are referred to in this paper: 
1. Rural Cancer Center Oncology Director (KA) 
2. Healthcare System Research Manager (SCM) 
3. Rural Cancer Center Radiation Oncologist (AB) 
4. Three rural cancer center medical oncologists (AW, FS, RB). 
                                                        





The four oncologists were selected because they are the primary physicians seeing 
patients at the rural cancer center and they have all expressed interest in participating in 
clinical research. The strategy ultimately developed needs to support these physicians, 
their patient population, and their research interests, so it was important to obtain their 
perspective on the research program. The oncology administrator was selected to 
participate since the research program is going to support her department and her 
physicians and the strategy needs to align with any oncology department requirements. 
The Healthcare System research manager was chosen for the needs assessment because 
the research program developed at the rural hospital ultimately reports to SCM and she 
can provide guidance on developing the implementation strategy from the research 
administration perspective. 
 
5.3.2. Selection of needs assessment questions 
 
 Based on the literature review discussed in section 5.2, planning a clinical trial 
portfolio and determining appropriate staffing became main criteria to include in the 
research program development strategy. Therefore, a needs assessment was created with 
a series of questions designed to ascertain from the respondents their opinions and 
recommendations regarding establishing a clinical trial portfolio and research staffing 
support at the rural hospital. The needs assessment questions also offered an opportunity 
for the respondents to provide additional insight into the research program development 
should they want to discuss other items beyond the scope of the clinical trial portfolio and 
staffing.  
 Three versions of the needs assessment were composed for this project. One 




administered to the oncology department director (Appendix 2), and the third version was 
given to the Healthcare System research manager (Appendix 3). The three versions of the 
needs assessment mostly contain the same questions, so for purposes of this discussion, 
the needs assessment for the oncology physicians will be referenced. Questions added or 
removed from the other two needs assessments will be mentioned as applicable. The 
needs assessments were designed to be administered in an interview format. The 
interview format was chosen because the author felt that stakeholder participation would 
be increased if the respondents could provide information through conversation rather 
than having to write responses. Additionally, the interview format allowed for follow-up 
questions and opportunities for clarification if needed. The needs assessment questions 
were divided into three sections. The first set of questions pertained to the clinical trial 
portfolio. The second set of questions queried the respondents on staffing needs, and the 
third set of questions were designed to give the author feedback on the respondents’ 
overall vision of the research program.  
For the clinical trial portfolio section, the intent of questions one, two, three, 
seven, and eight was to determine the interviewees’ basic requests for clinical trials to 
open at the rural hospital. This information would be used to steer the author in the right 
direction of which types of trials the stakeholders believe should be completed at the rural 
hospital and which types of studies are of interest to them.  
The purpose of questions four and nine was to allow the respondents to expound 
on the previous questions with open-ended responses. It was anticipated that these open-
ended answers may provide an opportunity for unexpected topics or concerns to arise that 




was included in order to gain perspective on why the stakeholders believe that it is 
important to be able to enroll patients at the rural hospital rather than refer patients. 
Question six addressed limitations at the rural facility. The responses received 
from this question are pertinent to understanding the feasibility of performing certain 
studies at the rural hospital.  
Question ten was included in an effort to comprehend how the stakeholders 
foresaw the rural hospital integrating with the existing oncology research program in the 
Healthcare System. The intent of the question was to understand whether the stakeholders 
desired autonomy when selecting clinical trials or whether the rural hospital was 
agreeable to only considering studies vetted by and opened at other hospitals in the 
Healthcare System.  
The Healthcare System research manager was not asked questions five, eight, and 
nine since these questions were specific to the clinical operations at the rural hospital. 
 The three questions in the staffing needs section were chosen in order to obtain 
feedback on stakeholder expectations for research personnel support. Question eleven 
was aimed at determining whether the physicians and administration would be accepting 
of clinic staff participating in research. Question twelve was asked in order to identify 
how much staff support the stakeholders believed that they needed to effectively maintain 
a research program on site. Question thirteen, an open-ended question, was included to 
gather additional information regarding the needs of the physicians and administrators 
and how the research staff could support these needs.  
 The third section was designed to be a series of open-ended questions to obtain 




these questions would ensure that the strategy for implementing the research program 
aligned with the needs and requirements of the oncology department at the rural hospital 
and the Healthcare System Office of Research. Question fourteen was specifically 
designed to assist with prioritizing research needs at the rural hospital. An additional 
question was asked of the oncology director and the research manager, which was “Do 
you have any other specific needs for the clinical research program that you would like to 
share?” The purpose of this open-ended question was to provide the administrators the 
opportunity to notify the author of any department specific items or concerns that should 
be considered during development of the strategy.  
 
5.3.3. Description of interview process 
 
 The needs assessment interviews were conducted individually with each 
respondent in one sitting. The author of this paper served as the interviewer and recorded 
each interviewee’s responses. The interview format allowed for discussion between the 
interviewer and interviewee. The interviewer provided prompts when needed as indicated 
in Appendices 1-3. 
5.4. Developing the Strategy 
 
 The second step in the project methodology was to combine the knowledge 
gained from the literature review with the information obtained from the needs 
assessment surveys and cancer registry data to develop the strategy for implementing a 
research program. The strategy for the rural hospital included two main parts: 
recommendations to staff the research program and recommendations for developing a 
clinical trial portfolio. The needs assessment responses and the literature review data 




rural hospital. Clinical trial portfolio recommendations were developed based on advice 
in the literature review and feedback from the needs assessment interviews. The cancer 
registry data was incorporated into this analysis as well to ensure that trials were 





Chapter 6. Project Results and Discussion 
 
 
6.1. Literature Review Assessment 
 
 Key points obtained from the literature review were organized into three 
categories: (1) choosing clinical trials for the site’s study portfolio, (2) determining 
staffing needs, and (3) making decisions for opening community-based research 
programs. For the first category, choosing clinical trials for the site’s study portfolio, the 
literature recommended the following: 
• A research site should open clinical trials specific to the patient population seen at 
the institution.57 
• A research site should offer clinical trials covering multiple types of treatments 
for a particular cancer.58 
• A research site should offer clinical trials for the same cancer type with different 
eligibility criteria so that patients can have options.59 
• A research site, depending on its capabilities, should have a diverse trial portfolio 
including options for healthy volunteers, Phase I, Phase II, Phase III, 
observational, registry, and tissue banking studies.60  
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• A research site with budget concerns should consider offering trials with more 
funding, such as industry-sponsored trials, to offset the costs of studies with 
limited funding, such as cooperative group trials.61 
For the second category, determining staffing needs, the following suggestions were 
provided in the literature: 
• A research site may benefit from hiring a research nurse to coordinate the clinical 
trials since the nurse can do both research and standard clinical assessments.62 
• A research site should involve clinical staff in the research process as a way to 
increase accrual and to assist the patient with navigating the research 
requirements along with the standard treatments.63 
• A research site should maintain metrics on trial volume and complexity to assist 
with managing staff workload.64 
The first two categories are generalizable to all research sites. However, the third 
category is specific to opening research programs at community-based facilities. The 
literature provides the following advice for choosing a clinical trial portfolio and 
appropriately staffing a new research program at a community-based hospital: 
• The research site should focus on opening studies with the highest potential for 
accrual.65 
 
                                                        
61 Baer et al., "Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial 
Sites," 328. 
62 Hastings, Fisher, and McCabe, 151-152. 
63 Barr, Crofton, and Lin, 450; Somkin et al.; St. Germain et al., 45-53.  
64 Good et al., 211-215; James et al., 1228-1233; Smuck et al., 80-84. 




• The research site should initially open chemotherapy studies since it is a common 
treatment and may have the most physician support.66  
• The research site should begin by opening less complex trials.67 
• The research site should thoroughly review study feasibility to ensure the protocol 
can properly be supported and executed at the site.68 
• The research site should hire a clinical research nurse to manage the clinical 
trials.69 
Recommendations in the first and second categories came from institutions of 
various sizes with some of those having larger established research programs. Therefore, 
not all of the suggestions were relevant for a new program in a smaller setting. For 
example, offering multiple clinical trials with different treatment options is most likely 
not possible for a nascent research program. While not all of the recommendations 
presented in this section may be implemented at the commencement of the research 
program, the concepts are valuable and should be retained as long-term goals for the 
research site. The suggestions given in the third category for new and community-based 
programs are all applicable to the strategy for developing a research program at the rural 
hospital. These were used as the foundation for the recommendations given to the rural 
cancer center for building its research program.  
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6.2. Needs Assessment Results 
 
 For ease of discussion, the question numbers used in the needs assessment 
administered to the oncology physicians (Appendix 1) are referenced throughout this 
section. Questions added to or omitted from the needs assessments administered to the 
rural hospital oncology director and Healthcare System research manager are mentioned 
as needed. With the exception of question seven, all of the questions with multiple choice 
options allowed more than one response to be given. The answers to the multiple-choice 
questions were tabulated and are presented throughout this section. To analyze the open-
ended questions, the responses were grouped into relevant categories. Given the limited 
number of respondents, the data is presented in charts as a function of the number of 
respondents providing a certain answer rather than the percentage of respondents. 
 The answers to questions one and two are presented in Figure 1 and Figure 2, 
respectively. These questions gave general feedback about the type of trials the 
stakeholders believe would be beneficial to have open at the rural cancer center. As 
expected, for question one, all of the respondents answered that Phase III studies would 
be appropriate for the rural cancer center, and five out of six respondents said that 
observational studies would be appropriate. Phase III and observational studies generally 
are less complex, and therefore, it is reasonable to want to focus on opening these studies 
at the rural cancer center. As noted by the oncology director (KA), the clinic staff would 
be more comfortable with these types of studies.70 While three of the respondents did 
answer that Phase II trials should be completed at the site, there is awareness that opening 
                                                        




such trials could be complicated. As the radiation oncologist (AB) stated, a Phase II trial 
may be “pushing it.”71  
 
 
Figure 1: Clinical trial types beneficial to the rural hospital population 
 
 For question two, all of the respondents agreed that clinical trials with 
pharmacological therapies, which include chemotherapy, hormonal therapy, and 
immunotherapy, would be beneficial to offer at the rural hospital. Four out of the six 
respondents felt that radiation therapy would be beneficial, which is most likely related to 
the fact that radiation therapy is available at the rural cancer center and that new radiation 
equipment was recently installed. Surgery was not as popular of an answer, which may be 
due to the fact that the oncology surgeons at the rural hospital are employed by an outside 
group and it may be more difficult to get the surgeons to participate in the studies.72 
                                                        
71 AB, interview by author, DeKalb, IL, February 14, 2019. 
72 RB, interview by author, DeKalb, IL, February 14, 2019. 











Figure 2: Treatment types beneficial to the rural hospital population 
 
 The Healthcare System research manager (SCM) was the only respondent, for 
question three, to answer that all types of research including cooperative group trials, 
industry sponsored trials, and investigator initiated trials should be conducted at the rural 
cancer center. The remaining five respondents all answered that investigator initiated 
trials should not be conducted at the rural hospital. Question four prompted the 
interviewees to explain their rationale. SCM stated that “All trials should be an option if 
the rural facility has the clinical expertise, facility requirements, and necessary support 
and training…”73 The other respondents, as presented in Figure 3, noted lack of 
appropriate research staffing support as a deterrent for opening investigator initiated 
trials. They also mentioned having limited time for conducting the trials and no funding 
being challenges. 
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Figure 3: Reasons to not include investigator initiated trials in the clinical trial portfolio 
 
 Question five was asked of the oncology program director and the four oncology 
physicians to get a better idea of why having a research program at the rural facility was 
important to them. The interviewees were asked an open-ended question about why 
patients should be enrolled on trials at the rural cancer center rather than being referred to 
another facility. Multiple responses were accepted, and they fell into four categories: (1) 
travel and patient convenience, (2) ease of patient care coordination, (3) ability to offer 
cutting-edge treatments at the rural hospital, and (4) patient retention on clinical trials. As 
seen in Figure 4, saving patients from having to travel far for their care was the most 
popular response with four out of the five respondents providing that answer. Two 
respondents felt that coordinating the patients’ care was easier when no referrals were 
necessary. One of the oncology physicians (RB) mentioned that he no longer wanted to 
refer patients because he wanted to offer novel treatments at the rural facility and because 








he also believed that patients would be more compliant with study protocols if they could 
receive treatment close to home.74 
 
 
Figure 4: Reasons for enrolling patients on clinical trials at the rural hospital rather than 
referring patients 
 
 Question six was asked to the stakeholders to gain an understanding of any 
limitations that exist at the rural hospital that need to be considered when developing a 
strategy for opening the clinical research program. This was an open-ended question 
where multiple responses were allowed. The responses fell into three categories: (1) lack 
of on-site research staff support, (2) lack of research training and experience for the clinic 
staff at the rural hospital, and (3) lack of medical equipment to complete protocol 
required tasks. Notably, as seen in Figure 5, all six respondents answered that not having 
on-site research personnel was a limitation to operating clinical trials at the hospital.   
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Figure 5: Limitations to opening clinical trials at the rural hospital 
 
 In an effort to understand what should drive the clinical trial portfolio at the rural 
hospital, the respondents were asked, in question seven, whether it was more important to 
have trials open which the site can accrue patients to or whether it was more important to 
have trials with novel treatment options. All six respondents answered that the ability to 
accrue to trials is most important. The oncology director and the oncology physicians 
were then asked, in questions eight and nine, which cancer sub-specialty should be a 
focus for opening clinical trials and why. All of the respondents answered that breast 
cancer should be a priority because it is the most prevalent cancer seen at the rural 
hospital.  
Since the rural hospital is part of a larger healthcare system with existing 
oncology research programs, question ten was asked of the respondents to get a better 
understanding of how they envision the rural hospital integrating with the other programs 
as far as sharing a clinical trial portfolio. Half of the respondents answered that the rural 
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hospital should be able to open any trials even if the trials are not open at other hospitals 
in the system. The other three respondents answered that the rural hospital should only 
open studies that are active at other hospitals in the system. This latter response implies 
that the rural hospital and the other system hospitals should share a master clinical trial 
portfolio rather than each hospital have autonomy to open any study that the physicians 
desire. Not all studies in the shared portfolio have to be open at each site, but a site 
cannot open a trial unless it has been vetted and is part of the master clinical trial 
portfolio. The concept of the master clinical trial portfolio is currently being reviewed by 
the Oncology Research Integration Committee. As of the writing of this paper, no 
decision has been made on whether the system hospitals must share a clinical trial 
portfolio, but the author felt it important to ascertain how the stakeholders felt about such 
a scenario in case the responses affected the strategy for developing the research 
program. Since the responses were split equally between the two responses, the 
recommendation provided by the author in this project regarding clinical trial portfolio 
development does not go into detail regarding where the studies are selected from but 
rather focuses on the feasibility selection process, which is applicable to both responses. 
The next set of questions queried the respondents on staffing needs at the rural 
cancer center. Question eleven asked the respondents whether a research coordinator 
should manage all aspects of the clinical trial, whether clinical staff should assist the 
research coordinator with study requirements, or whether clinical staff should handle the 
research studies and no study coordinator is needed. All six of the respondents answered 
that there should be collaboration between the clinic and research staff where clinic staff 




The interviewees were then asked, in question twelve, what type of staffing 
support was needed. As shown in Figure 6, four of the six respondents answered that a 
part-time coordinator was needed. One respondent was agreeable to a coordinator on an 
as-needed basis. The Healthcare System research manager (SCM) answered that a 
program manager would be a good staffing solution. SCM provided further clarification 
that a program manager might be the best option for staffing the rural cancer center 
initially since a manager can handle all aspects of the study including start-up, regulatory, 
and enrollment.75 It is somewhat surprising that regulatory support was not mentioned by 
the interviewees. However, this could be due to the interviewees considering this job the 
responsibility of a study coordinator rather than a separate position. It was also 
unexpected that none of the respondents answered that a fulltime coordinator was needed 
given the result from question six that lack of on-site research support was a limitation to 
opening clinical trials. Perhaps this response indicates the understanding that a fulltime 
coordinator may be unrealistic until the need, through increased patient accruals and 
trials, is established. 
 
                                                        





Figure 6: Staffing support needs at the rural hospital 
 
 Question thirteen further addressed staffing needs by asking respondents the 
benefits of having fulltime research staff at the site. This was an open-ended question, 
and responses were grouped into three categories: (1) capacity to increase accrual and 
number of trials available, (2) research staff are consistently available to guide 
investigators and study protocols, and (3) the ability to establish the site as a research 
facility and promote future growth. The most popular response, as demonstrated in Figure 
7, was that having research staff on site would increase patient accrual and allow more 
trials to be open at the site.  
 











Figure 7: Benefits of having research support staff at the rural hospital fulltime 
 
 Question fourteen was asked of all six respondents in an open-ended format. 
Ideally, all respondents would have provided their top three requirements that need to be 
in place to effectively support research at the rural hospital, but not all respondents were 
able to give three answers because they thought the one or two responses given 
adequately addressed the question. The responses varied but were able to be categorized 
into five areas of need: (1) consistent research support, (2) trial reminders as a way to 
better engage investigators and clinical staff, (3) clinic staff education, (4) access to more 
trials, and (5) adequate facilities and equipment. As shown in Figure 8, five out of six 
respondents indicated that consistent research support needs to be in place for an 
effective research program. The consistency of research support was emphasized in the 
response by KA when she requested a coordinator be present on specific days so that the 
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Establishes site as a research facility and
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staff is aware of when research support will be on site.76 The importance of consistency is 
also echoed in the responses by FS, AW, and AB in that they requested regular access to 
a study coordinator for screening and protocol questions.77 Trial reminders was another 
frequent response, which included requests for summary pages for each study to be 




Figure 8: Top reported needs for opening and managing a clinical trial at the rural 
hospital 
 
Question fifteen asked each respondent what his or her vision was for the rural 
oncology research program in five years. This was an open-ended question that resulted 
in discussion between the interviewer and interviewees, but in the end, all of the 
responses came down to the stakeholders wanting to see the rural cancer center fully 
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operational from a research program perspective. FS specifically mentioned wanting to 
see a significant increase in accrual in five years,79 and KA wanted at the end of five 
years for the cancer center staff to “always be thinking about research participation when 
seeing a patient.”80 AB also commented that in five years that there should be no need to 
refer patients to another facility for clinical trial participation because the rural cancer 
center will offer the same study opportunities available at the other Healthcare System 
locations.81 
 Question sixteen, an open-ended question, allowed respondents to remark on the 
culture of research at the rural cancer center and what could be improved to make the 
facility more conducive to conducting research. The interviewer attempted to obtain three 
responses from each participant, but not everyone was able to supply three answers as he 
or she was satisfied with the one or two answers provided. The responses are represented 
in Figure 9 and were categorized into the following needs: (1) research education for 
clinic staff and physicians, (2) not overloading clinic staff with research responsibilities, 
(3) incorporating research into the clinic workflow, (4) having research personnel on site 
to champion the research process, and (5) having allotted time for investigators to 
complete research tasks. 
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Figure 9: Top reported needs for creating a culture of research at the rural hospital 
 
 One final question was asked of the oncology program director and the Healthcare 
System research manager, which allowed them to comment on any specific requirements 
that should be included or followed when setting-up the research program at the rural 
hospital. The Healthcare System research manager (SCM) provided feedback that the 
research program at the rural hospital needs to integrate well with existing workflows, 
and that the rural cancer center needs to be adequately staffed with trained personnel to 
effectively support quality research.82 The request from the oncology director (KA) was 
that the research program provide adequate training for clinic staff and maintain frequent 
communication with the clinic staff and physicians, which may include attending staff 
meetings at the rural cancer center.83  
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6.3. Cancer Registry Data Analysis 
 
A report was obtained from the cancer registry at the rural hospital based on 2017 
data, which was the most current data available. The report contained information on the 
prevalence of certain cancers treated at the rural cancer center, the most common stage of 
those cancers that are treated, and the treatments frequently used for those cancers. As 
demonstrated in Table 1, twenty percent of the cases seen at the rural hospital are breast 
cancer, and this is the most predominant cancer diagnosed and treated at the cancer 
center. The incidence of lung cancer cases is the next highest at eleven percent followed 
by prostate cancer making up nine percent of the cases. Table 1 also presents data 
regarding which stage of cancer is most frequently diagnosed and the common treatment 
strategies for the cancer type and stage. Of the breast cancer cases seen at the rural 
hospital, the majority of cases are diagnosed and treated while they are stage I or stage II 
cancers, and the most common treatments are surgery and hormonal therapy. Almost half 
of the lung cancer cases are diagnosed and treated as a stage IV cancer with 
chemotherapy and immunotherapy being the most common treatments. Over half of the 
prostate cancers are treated as a stage II cancer with radiation and hormonal therapy 
being used frequently as treatment.84  This information is important to understanding the 
patient population seen at the rural hospital so that the clinical trial portfolio can be 




                                                        





Table 1. Top three cancer types diagnosed and treated at the rural cancer center, 
2017 
Cancer Type % of Cancer Cases Common Stage at 
Diagnosis 
Common Treatment 
for Cancer and 
Stage 
Breast 20 I, II Surgery, Hormone 
 
Lung 11 IV Chemotherapy, 
Immunotherapy 
 
Prostate 9 II Radiation, Hormone 
Source: Data from Rural Hospital Cancer Registry, First Course Treatment by Best AJCC Stage Report, 









 Based on the literature review results, the needs assessment results, and the data 
from the cancer registry, a strategy was developed for implementing an oncology clinical 
research program at the rural hospital. The strategy consisted of six recommendations, 
which focused on managing an effective clinical trial portfolio and appropriately staffing 
the research program in order to provide adequate support to the physician investigators 
and to manage the protocol requirements.  
 
Recommendation 1: Develop a Process for Managing the Clinical Trial Portfolio  
 
 Both the literature review and the needs assessment results indicated the 
importance of being able to accrue to studies. The research site could take a significant 
financial loss by opening studies with limited to no accrual.85 Only clinical trials should 
be opened at the site that make sense for the facility based on the patient population seen 
at the cancer center, the equipment available at the site to perform protocol requirements, 
and the interest of the physicians.  
 Therefore, the recommendation is to convene a research protocol feasibility 
committee comprised of the four oncology physicians at the rural cancer center. Porter et 
al. suggested using disease teams to review protocol feasibility.86 The Healthcare System 
oncology program does have disease teams that encompass the cancer programs at all of 
the system hospitals, including the rural hospital. However, the oncologists at the other 
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hospitals are not aware of site limitations and needs at the rural cancer center, and 
therefore, the recommendation is to initially keep the feasibility assessment local with the 
rural cancer center physicians reviewing the studies. As the research program grows at 
the rural cancer center, use of the system-wide disease teams to review protocol 
feasibility may be an option. Using the research protocol feasibility committee to review 
studies should result in a clinical trial portfolio which the physicians are enthusiastic 
about and that is applicable to the hospital’s patient population so that significant accrual 
rates can be achieved. The second part of this recommendation is that the research 
protocol feasibility committee require documentation from the principal investigator 
demonstrating the ability to accrue to the trial. This would follow a process similar to the 
one implemented by Durivage and Bridges, and one can anticipate having the same 
success with reducing the amount of studies opened with limited or no accrual.87 
 
Recommendation 2: Include Studies in the Clinical Trial Portfolio that will be 
Successful at the Rural Cancer Center  
 The literature review provided multiple suggestions for what types of trials to 
incorporate in a clinical trial portfolio. One article placed emphasis on the need to offer 
trials for all cancer types and stages of cancer seen at a research facility.88 Another article 
noted the importance of offering a diverse portfolio including Phase I, Phase II, Phase III, 
registry, and observational studies.89 These articles provide reasonable suggestions for 
more established or larger programs. However, the recommendation for the clinical trial 
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portfolio at the rural hospital, given that the program is new and at a small facility, is to 
focus on opening studies likely to succeed at the rural cancer center rather than trying to 
choose studies to cover all cancer types and include all types of studies. Therefore, the 
clinical trial portfolio at the rural cancer center should be established using the following 
criteria: 
• The research site should open studies with the highest potential for accrual.90 
• The research site should initially open chemotherapy studies.91  
• The research site should open less complex trials,92 such as Phase III, 
observational, or registry studies. 
 
Recommendation 3: Initially Open Breast, Lung, and Prostate Cancer Studies at the 
Rural Hospital 
Using suggestions from the literature review and the data obtained from the rural 
hospital’s cancer registry, the recommendation is to initially open breast, lung, and 
prostate cancer studies since these are the most prevalent cancers seen at the hospital. The 
site has the best opportunity for accruing patients to these trials. One or two trials should 
be opened for each of these cancer types, and the trials should focus on treating stage I or 
II breast cancers, stage II prostate cancers, and stage IV lung cancers since those are the 
most commonly diagnosed stages of cancer at the rural hospital. The studies should be 
Phase III, observational, or registry studies so that the site can begin with less complex 
trials. The Phase III interventional trials should include chemotherapy as treatment. Since 
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hormone treatment is popular for both breast and prostate cancers at the site, then those 
treatments could be incorporated into the trial portfolio as well. From a budget 
perspective, the recommendation is that one or two of the studies should be industry-
sponsored to help offset the costs from the cooperative group trials. It is not 
recommended to open any investigator initiated trials until the research program is more 
established at the site, the research personnel and principal investigators gain more 
experience, and the investigators are able to designate specific time for research.  
 The responses from the needs assessment were also incorporated into 
recommendations 1-3 regarding the clinical trial portfolio. The needs assessment 
responses corresponded with the literature review in that the stakeholders were most 
interested in completing Phase III or observational studies and agreed that investigator 
initiated studies were not appropriate for opening at a new research site. The needs 
assessment results also supported the recommendation to open breast cancer trials and to 
focus on pharmacological treatments.    
 
Recommendation 4: Hire a Clinical Research Nurse 
 
 The needs assessment identified the lack of on-site research personnel to be one 
of the biggest limitations to opening clinical trials at the rural hospital. Having consistent 
research staff available was also listed as a key item currently missing to create a culture 
of research at the rural hospital. Utilizing this feedback along with the literature review 




 The recommendation for staffing the research program is to hire a clinical 
research nurse as suggested by Hastings et al.93 The research nurse should begin as a 
part-time position and have the opportunity for fulltime status as the research program 
grows. The research nurse should be in charge of all study activities including 
coordinator responsibilities and regulatory submissions until trial volume indicates the 
need for additional staff. The position may also transition into a manager level role as 
proposed by the Healthcare System research manager (SCM).94 The needs assessment 
responses regarding staffing provided support for this recommendation. The majority of 
respondents agreed that a part-time coordinator would be sufficient. In addition, the 
research nurse should have a consistent schedule at the rural cancer center to fulfill the 
request identified in the needs assessment that the investigators and clinic staff have 
regular access to research coordinator support.  
The research nurse can also prepare protocol summaries complete with eligibility 
criteria and give these to the clinic staff and physicians for reference.95 Ideally, the 
summary sheets should be pocket-sized cards for staff to carry with them to patient visits 
and to be easily accessible. 
 
Recommendation 5: Provide Education for the Clinic Staff and Physicians on 
Research Activities 
Part of the staffing recommendation is to also educate the clinic staff and 
physicians on research activities so that they can participate in the research process. The 
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stories of successful partnerships between research personnel and clinic staff96 signify the 
need to establish this collaborative environment at the rural hospital from the onset of the 
research program. Based on a suggestion from the needs assessment interviews, 
education can be accomplished by the clinical research nurse attending clinic staff 
meetings to discuss research and give updates on study protocols.97  
 
Recommendation 6: Track Study Metrics to Monitor Research Personnel Workload 
 
The final recommendation is that the rural cancer center research personnel, with 
the assistance of the Healthcare System Office of Research, should track study metrics in 
order to monitor research personnel workload. A clinical trial complexity scoring system 
should be used like that identified by Good et al. or Smuck et al.98 Implementing the 
tracking of these metrics at the beginning of the research program will allow the site to 
maintain constant oversight of research support needs and make efficient hiring 
decisions. The clinical trial management system used by the Healthcare System Office of 
Research can be modified to collect and report this data. 
 
  
                                                        
96 Barr, Crofton, and Lin, 450; Somkin et al.; St. Germain et al.  
97 KA, interview. 








 A strategy to implement an oncology clinical research program at the rural 
hospital was developed to meet the needs of the Healthcare System. The Oncology 
Research Integration Committee designated the expansion of clinical research to the 
Healthcare System community hospitals a priority for the fiscal year. Part of this 
expansion initiative required that infrastructure be in place at the rural hospital to support 
the clinical trials. The rural hospital is also attempting to earn its CCP accreditation 
through the Commission on CancerⓇ. Accruing to clinical trials is a standard that must be 
met for accreditation, and having a research program is necessary to aid the rural hospital 
in meeting this requirement. Lastly, the integration between the oncology research 
program at the rural cancer center and other Healthcare System cancer centers resulted in 
the rurally based oncologists requesting equitable research support at their facility. 
Having a research program at the rural cancer center allows the physicians to enroll 
patients locally onto trials and to maintain oversight of the patients’ care rather than 
having to refer patients to other locations. 
 The strategy developed for the rural hospital research program was designed after 
best practices shared in the literature by other institutions starting and managing clinical 
research programs. A needs assessment with key stakeholders supplemented the literature 
review by providing insight into the specific requests of the oncology physicians and 
administrators in the oncology and research departments. These two sources of 
information along with cancer registry data were analyzed to yield a strategy devised to 




portfolio and staffing the cancer program are noted to be key items in managing a 
successful research program.99 Therefore, the strategy delivered for this project focuses 
on building a clinical trial portfolio of studies which the site can easily accrue patients to, 
using the rural oncologists to assess study feasibility, educating the clinical staff on 
research activities, and appropriately staffing the research program to manage the trial 
workload while also supporting the investigators.  
The recommendations provided in the strategy are meant to guide the initial start-
up of the research program at the rural hospital. However, the rural cancer center 
physicians and administrators have a vision that the research program should grow. As 
the research program matures, the recommendations should be adapted to support a larger 
more experienced research site. The logic behind the recommendations can remain the 
same, which is to open studies that can successfully accrue patients at the rural hospital 
and to provide enough staff for the research program to support quality research. For 
example, after successfully supporting Phase III, observational, or registry studies, the 
site feasibility committee could decide to open a Phase II trial. Studies in other areas 
besides breast, lung, and prostate cancer could be opened to accommodate more patients. 
Research staffing must also grow to support additional trials and increased enrollment. 
Hiring other research positions could be considered such as regulatory specialists and 
data entry personnel to support the study coordinator. 
A future direction for this project is to expand the strategy beyond oncology to 
other areas at the rural hospital. The rural hospital is integrated with the Healthcare 
System in multiple medical specialties, including cardiology and neurology. Both of 
                                                        




these departments have active clinical research programs in the Healthcare System, and 
there is opportunity for research to expand to the rural hospital in these areas as well. 
Therefore, the strategy developed in this project for oncology could be catered to the 
specific needs of a cardiology research program or a neuroscience research program at 
the rural hospital. There could be opportunity for the cardiology or neurology research 
programs to utilize some of the research infrastructure already put in place for the 
oncology program such as education of clinic staff or sharing research personnel. The 
clinical trial portfolio recommendations could be modified to reflect the cardiology or 
neurology populations seen at the rural hospital, and a feasibility committee of applicable 
cardiologists or neurologists could be utilized to drive development of the trial portfolios. 
Whether the strategy developed for implementing a research program is used only for 
oncology or whether it has the potential to be used in other departments, the goal remains 
the same, which is to establish a research program that meets the needs of the Healthcare 
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Appendix 1: Needs Assessment Questions for the Oncology Physicians 
 
 
Thank you for taking the opportunity to speak with me regarding development of 
an oncology clinical research program at your hospital cancer center. The intent of this 
interview is to obtain your feedback on what staffing support is needed to open a clinical 
research program at the hospital as well as what types of trials you think would be 
beneficial to have open. There will also be the opportunity for you to share your vision 
for the research program at the hospital. The results of the interviews will be compiled 
and used in partial fulfillment of my Master of Science in Research Administration at 
Johns Hopkins University. The results will also be shared with Northwestern Medicine 
Office of Research Administration and the Oncology Program Administration. 
 
Clinical Trial Portfolio 
 
1.  In which types of clinical trials are you interested in participating? The following 
prompts will be given… 
a. Investigational drug studies – Phase I 
b. Investigational drug studies – Phase II 
c. Investigational drug studies – Phase III 
d. Observational studies 
e. Device studies 
2. Thinking about the patients that you see routinely, which study treatment options 
would they benefit from most? The following prompts will be given…. 
a. Pharmacological treatments (chemotherapy, hormonal, molecular targeted 
therapy) 
b. Surgical treatments 
c. Radiation treatments 
3. What types of research do you NOT think are necessary to have in the clinical 
trial portfolio? The following prompts will be given… 
a. Cooperative group trials  
b. Industry sponsored trials 
c. Investigator initiated trials 
d. None of the above – cooperative, industry sponsored, and investigator 
initiated trials should all be included. 
4. What is the primary reason you answered ____________ to the last question? 
5. What are the main reasons that you would prefer to enroll patients in studies at 
your hospital rather than refer patients to a clinical trial elsewhere, even if it is a 
referral to a hospital in the same healthcare system? (Interviewer will attempt to 
obtain at least 3 reasons.) 
6. Thinking about the current state of the hospital, what potential limitations do you 
see in trying to open clinical trials at the hospital? (Interviewer will attempt to 
obtain at least 3 limitations.) 




a. The ability to accrue to the trial. 
b. The ability to offer a novel treatment to patients. 
8. If you had to choose an oncology sub-specialty area on which to focus opening 
clinical trials first, which would it be?  
9. What is the primary reason you answered _____________ to the last question? 
10. In regards to opening new clinical trials, which of the following statements do you 
agree with? 
• A: Any study that is open at the other regional hospitals should 
automatically be opened at the rural hospital. 
• B: The rural hospital should only open studies that are available at the 
other regional hospitals, but not all studies will be opened. 
• C: The rural hospital should be able to open a study, even if it is not 
available at the other regional hospitals. 
• A only 
• B only 
• C only 
• A and B 
• A and C 
• B and C 
Staffing Needs 
11. What is your expectation for research staffing support? The following prompts 
may be given… 
a. A research coordinator should manage all study logistics. Clinic staff 
should have no or limited involvement in the clinical trials. 
b. The research coordinator will manage the study logistics, but clinic staff 
will be available to assist the coordinator with study requirements. 
c. Clinic staff will manage the study logistics. A research coordinator is not 
needed or will have minimal involvement. 
12. How much research staffing support do you need? The following prompts will be 
given… 
a. Fulltime coordinator 
b. Part-time coordinator 
c. Coordinator on an as needed basis 
d. Regulatory Support 
e. Other….please explain 
13. What are the potential benefits of having research support, such as a study 
coordinator, on site at the hospital fulltime? (The interviewer will attempt to 






Specific Needs and Overall Vision 
14. As a physician investigator, what are the top 3 things you need right now as far as 
research support to effectively open and manage a clinical trial at the rural 
hospital? 
15. What is your vision for the clinical research program at the rural hospital in five 
years?  
16. What are the top 3 things you think need to be done at the hospital to create a 





Appendix 2: Needs Assessment Questions for the Rural Hospital 
Oncology Program Director 
 
 
Thank you for taking the opportunity to speak with me regarding development of 
an oncology clinical research program at the hospital cancer center. The intent of this 
interview is to obtain your feedback regarding staffing support that is needed to open a 
clinical research program at the hospital, what types of trials you think would be 
beneficial to the oncology program to have open, and your vision to ensure that the 
research program at the hospital aligns with your department strategy.  The results of the 
interviews will be compiled and used in partial fulfillment of my Master of Science in 
Research Administration at Johns Hopkins University. The results will also be shared 
with Northwestern Medicine Office of Research Administration and the Oncology 
Program Administration. 
 
Clinical Trial Portfolio 
 
1. Based on the patient population seen at the hospital, which of the following types 
of clinical trials do you think would be most beneficial to the patients? The 
following prompts will be given... 
a. Investigational drug studies – Phase I 
b. Investigational drug studies – Phase II 
c. Investigational drug studies – Phase III 
d. Observational studies 
e. Device studies 
2. Thinking about the patients seen routinely at the hospital, which of the following 
study treatment options would be most beneficial to offer the patients? The 
following prompts will be given… 
a. Pharmacological treatments (chemotherapy, hormonal, molecular targeted 
therapy) 
b. Surgical treatments 
c. Radiation treatments 
3. What types of research do you NOT think are necessary to have in the clinical 
trial portfolio? The following prompts will be given… 
a. Cooperative group trials  
b. Industry sponsored trials 
c. Investigator initiated trials 
d. None of the above – cooperative, industry sponsored, and investigator 
initiated trials should all be included. 
4. What is the primary reason you answered ____________ to the last question? 
5. What are the main reasons that you think patients should be enrolled in studies at 
your hospital rather than refer patients to a clinical trial elsewhere, even if it is a 
referral to a hospital in the same healthcare system? (Interviewer will attempt to 




6. Thinking about the current state of the hospital, what potential limitations do you 
see in trying to open clinical trials at the hospital? (Interviewer will attempt to 
obtain at least 3 limitations.) 
7. What do you think is more important in choosing whether or not to open a trial?  
a. The ability to accrue to the trial. 
b. The ability to offer a novel treatment to patients. 
8. If you had to choose an oncology subspecialty area on which to focus opening 
clinical trials first, which would it be?  
9. What is the primary reason you answered _____________ to the last question? 
10. In regards to opening new clinical trials, which of the following statements do you 
agree with? 
• A: Any study that is open at the other regional hospitals should 
automatically be opened at the rural hospital. 
• B: The rural hospital should only open studies that are available at the 
other regional hospitals, but not all studies will be opened. 
• C: The rural hospital should be able to open a study, even if it is not 
available at the other regional hospitals. 
• A only 
• B only 
• C only 
• A and B 
• A and C 
• B and C 
Staffing Needs 
11. What is your expectation for research staffing support in your department? The 
following prompts may be given: 
a. A research coordinator should manage all study logistics. Clinic staff 
should have no or limited involvement in the clinical trials. 
b. The research coordinator will manage the study logistics, but clinic staff 
will be available to assist the coordinator with study requirements. 
c. Clinic staff will manage the study logistics. A research coordinator is not 
needed or will have minimal involvement. 
12. How much research staffing support do you need? The following prompts will be 
given… 
a. Fulltime coordinator 
b. Part-time coordinator 
c. Coordinator on an as needed basis 
d. Regulatory Support 




13. What are the potential benefits of having research support, such as a study 
coordinator, on site at the hospital fulltime? (The interviewer will attempt to 
obtain 3 benefits.) 
Overall Vision 
14. As the oncology program director, what are the top 3 things you need right now as 
far as research support to effectively open and manage a clinical trial at the rural 
hospital? 
15. What is your vision for the clinical research program at the rural hospital in five 
years?  
16. What are the top 3 things you think need to be done at the hospital to create a 
culture of research? 
17. Do you have any other specific needs for the clinical research program that you 






Appendix 3: Needs Assessment Questions for the Healthcare System 
Research Manager 
 
Thank you for taking the opportunity to speak with me regarding development of 
a clinical research program at the rural hospital. The intent of this interview is to obtain 
your feedback regarding staffing support that is needed to open a clinical research 
program at the hospital, what types of trials you think would be beneficial to the 
oncology program to have open, and your vision to ensure that the research program at 
the hospital aligns with existing research program strategies. The results of the interviews 
will be compiled and used in partial fulfillment of my Master of Science in Research 
Administration at Johns Hopkins University. The results will also be shared with 
Northwestern Medicine Office of Research Administration and the Oncology Program 
Administration. 
 
Clinical Trial Portfolio 
 
1. Based on what you know about the patient population seen at the hospital and 
trials available elsewhere in the Healthcare System, which of the following types 
of clinical trials do you think would be most beneficial to have available at the 
rural hospital? The following prompts will be given… 
a. Investigational drug studies – Phase I 
b. Investigational drug studies – Phase II 
c. Investigational drug studies – Phase III 
d. Observational studies 
e. Device studies 
2. Thinking about the patients seen routinely at the hospital and trials available 
elsewhere in the Healthcare System, which of the following study treatment 
options would be most beneficial to offer the patients at the rural hospital? The 
following prompts will be given… 
a. Pharmacological treatments (chemotherapy, hormonal, molecular targeted 
therapy) 
b. Surgical treatments 
c. Radiation treatments 
3. What types of research do you NOT think are necessary to have in the clinical 
trial portfolio at the rural hospital? The following prompts will be given… 
a. Cooperative group trials  
b. Industry sponsored trials 
c. Investigator initiated trials 
d. None of the above – cooperative, industry sponsored, and investigator 
initiated trials should all be included 
4. What is the primary reason you answered ____________ to the last question? 
5. Thinking about the current state of the hospital, what potential limitations do you 
see in trying to open clinical trials at the hospital? (Interviewer will attempt to 




6. What do you think is more important in choosing whether or not to open a trial?  
a. The ability to accrue to the trial. 
b. The ability to offer a novel treatment to patients. 
7. In regards to opening new clinical trials, which of the following statements do you 
agree with? 
• A: Any study that is open at the other regional hospitals should 
automatically be opened at the rural hospital. 
• B: The rural hospital should only open studies that are available at the 
other regional hospitals, but not all studies will be opened. 
• C: The rural hospital should be able to open a study, even if it is not 
available at the other regional hospitals. 
• A only 
• B only 
• C only 
• A and B 
• A and C 
• B and C 
Staffing Needs 
 
8. What is your expectation for research staffing support at the rural hospital? The 
following prompts may be given… 
a. A research coordinator should manage all study logistics. Clinic staff 
should have no or limited involvement in the clinical trials. 
b. The research coordinator will manage the study logistics, but clinic staff 
will be available to assist the coordinator with study requirements. 
c. Clinic staff will manage the study logistics. A research coordinator is not 
needed or will have minimal involvement. 
9. In your experience, how much research staffing support do you think the rural 
hospital needs to begin implementing clinical trials? The following prompts will 
be given… 
a. Fulltime coordinator 
b. Part-time coordinator 
c. Coordinator on an as needed basis 
d. Regulatory Support 
e. Other….please explain 
10. What are the potential benefits of having research support, such as a study 
coordinator, on site at the hospital fulltime? (The interviewer will attempt to 










11. As the Manager of Research, what are the top 3 things you think need to be in 
place right now as far as research support to effectively open and manage a 
clinical trial at the rural hospital? 
12. What is your vision for the clinical research program at the rural hospital in five 
years?  
13. What are the top 3 things you think need to be done at the hospital to create a 
culture of research? 
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